The Government Accountability Office today appointed five new members to the Medicare Payment Advisory Commission and reappointed one current member. The new members are former AHA Chairman Jonathan Perlin, M.D., president of clinical services and chief medical officer of HCA in Nashville, TN; Jaewon Ryu, M.D., executive vice president and chief medical officer for Geisinger Health System in Danville, PA; Karen DeSalvo, M.D., professor of medicine and population health at the Dell Medical School at the University of Texas in Austin and former U.S. Department of Health and Human Services Assistant Secretary for Health under the Obama Administration; Marjorie Ginsburg, founding executive director of the Center for Healthcare Decisions, Inc.; and Jonathan Jaffery, M.D., professor of medicine at the University of Wisconsin School of Medicine and Public Health in Madison. AHA formally nominated Perlin and nominated Ryu in conjunction with America’s Health Insurance Plans. Susan Thompson, RN, senior vice president of integration and optimization with UnityPoint Health in West Des Moines, IA, was reappointed to the commission. Their terms expire in April 2021.

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…